Showing studies matching your search2 results shown
Studies (2 shown)
NCT06911944PHASE4NOT_YET_RECRUITING
Amyloid Lowering for Alzheimer's in Down's With Donanemab Investigation
Sponsor · Michael Rafii, MD, PhDCondition · Down Syndrome (DS), Down Syndrome (Trisomy 21)Intervention · Donanemab, PlaceboUpdated May 2026
NCT07167966PHASE2NOT_YET_RECRUITING
Alzheimer's Tau Platform: Regimen A - AADvac1
Sponsor · Paul S. AisenCondition · Preclinical Alzheimer's Disease, Prodromal Alzheimer's DiseaseIntervention · AADvac1, DonanemabUpdated Apr 2026
Showing top 2 results. See all 2 results on CT.gov →